首页> 外文期刊>Drugs of the Future >24TH Symposium of the EORTC-NCI-AACR - Molecular targets and cancer therapeutics: Dublin, Ireland - November 6-9, 2012
【24h】

24TH Symposium of the EORTC-NCI-AACR - Molecular targets and cancer therapeutics: Dublin, Ireland - November 6-9, 2012

机译:EORTC-NCI-AACR第24届研讨会-分子靶标和癌症疗法:爱尔兰都柏林-2012年11月6日至9日

获取原文
获取原文并翻译 | 示例
           

摘要

The 24th Symposium on Molecular Targets and Cancer Therapeutics was jointly hosted by the European Organization for Research and Treatment of Cancer (EORTC), the NCI and the American Association of Cancer Research (AACR). Held in Dublin, Ireland, the meeting attracted approximately 2,000 international academics, clinicians and industry experts to discuss recent developments in drugs, targets and new discoveries in molecular biology. The meeting comprised over 600 poster and 55 oral presentations with diverse topics, including the development of novel pathway inhibitors, genetics of disease and clinical trial design.
机译:欧洲癌症研究与治疗组织(EORTC),NCI和美国癌症研究协会(AACR)共同主办了第24届分子靶标和癌症治疗学研讨会。会议在爱尔兰都柏林举行,吸引了大约2,000名国际学者,临床医生和行业专家,讨论了药物的最新进展,靶标和分子生物学的新发现。会议包括600多个海报和55个口头演讲,主题各异,包括新型途径抑制剂的开发,疾病遗传学和临床试验设计。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号